𝔖 Bobbio Scriptorium
✦   LIBER   ✦

Angiography of Hepatic Vascular Malformations Associated with Hereditary Hemorrhagic Telangiectasia

✍ Scribed by Manabu Hashimoto; Etuko Tate; Toshiaki Nishii; Jiro Watarai; Takanobu Shioya; Robert I. White

Publisher
Springer
Year
2003
Tongue
English
Weight
118 KB
Volume
26
Category
Article
ISSN
1432-086X

No coin nor oath required. For personal study only.

πŸ“œ SIMILAR VOLUMES

Bevacizumab to treat complicated liver v
Bevacizumab to treat complicated liver vascular malformations in hereditary hemorrhagic telangiectasia: A word of caution
✍ Elisabetta Buscarini; Guido Manfredi; Alessandro Zambelli πŸ“‚ Article πŸ“… 2008 πŸ› John Wiley and Sons 🌐 English βš– 45 KB

We read with interest the article by Mitchell et al. 1 dealing with bevacizumab treatment of a patient with hereditary hemorrhagic telangiectasia (HHT), cardiac failure, and portal hypertension due to severe liver vascular malformations (VMs). The treatment reversed the need for liver transplantatio

Characterization of 17 novel endoglin mu
Characterization of 17 novel endoglin mutations associated with hereditary hemorrhagic telangiectasia
✍ Urszula Cymerman; Sonia Vera; Amna Karabegovic; Salma Abdalla; Michelle Letarte πŸ“‚ Article πŸ“… 2003 πŸ› John Wiley and Sons 🌐 English βš– 643 KB

Hereditary hemorrhagic telangiectasia type 1 (HHT1) is a vascular dysplasia caused by mutations in the endoglin (ENG) gene and associated with epistaxis, telangiectases, and a high incidence of pulmonary arteriovenous malformations. To efficiently detect deletions and insertions, we optimized a quan